November Research Rounds
PRiME Research Rounds is a monthly research presentation featuring talks from PRiME Principal Investigators and Fellows. The seminar sessions bring the PRiME community together for engaging discussions!
Date: Friday, November 27, 2026, 1:00 - 2:00PM (Light refreshments will be provided)
Location: Red Seminar Room, Terrence Donnelly Centre, 160 College Street
Speakers:
Tim Corson
PRiME PI
Professor and Co-Director, Graduate Department of Pharmaceutical Sciences
Affiliate Scientist, Donald K. Johnson Eye Institute
“Novel mediators of angiogenesis: from biology to therapy”
Dr. Corson is a Professor at the Leslie Dan Faculty of Pharmacy and in the Department of Ophthalmology and Vision Sciences, Temerty Faculty of Medicine. He is Co-Director of the Graduate Department of Pharmaceutical Sciences, a member of PRiME and the Vision Science Research Program, and an Affiliate Scientist at the Donald K. Johnson Eye Institute, UHN. He holds HonBSc, MSc, and PhD degrees from UofT, and completed a CIHR-funded postdoctoral fellowship in chemical biology with Craig Crews at Yale University. He established his lab in 2010 at Indiana University School of Medicine in the Department of Ophthalmology, where he became Vice-Chair for Basic and Translational Research, before serving as Chair of the Department of Pharmacology and Toxicology, where he continues to hold an adjunct appointment. His research focuses on the discovery and targeting of pathways toward therapy for eye disease indications. He is an author on over 110 publications and inventor on 13 patents, with intellectual property optioned and/or licensed to multiple companies. His lab is currently supported by grants from the NIH, NSERC, CIHR, and the Retina Research Foundation. Selected awards include the Merrill Grayson Senior Chair and a Showalter Scholar at the Indiana University School of Medicine, an Entrepreneur-in-Residence at the Indiana Center for Biomedical Innovation, a Watanabe Translational Scholar of the Indiana Clinical and Translational Sciences Institute, and an ARVO Gold Fellow. He is on the editorial board of several journals and served as Chair of the NIH Pathobiology of Eye Disease 1 study section as well as reviewing for public and private funders in the US, Canada, UK, Europe, and Australasia.
Speaker TBC